Literature DB >> 19442255

The role of recombination in telomere length maintenance.

Nicola J Royle1, Aarón Méndez-Bermúdez, Athanasia Gravani, Clara Novo, Jenny Foxon, Jonathan Williams, Victoria Cotton, Alberto Hidalgo.   

Abstract

Human telomeres shorten during each cell division, predominantly because of incomplete DNA replication. This eventually results in short uncapped telomeres that elicit a DNA-damage response, leading to cellular senescence. However, evasion of senescence results in continued cell division and telomere erosion ultimately results in genome instability. In the long term, this genome instability is not sustainable, and cancer cells activate a TMM (telomere maintenance mechanism), either expression of telomerase or activation of the ALT (alternative lengthening of telomeres) pathway. Activation of the ALT mechanism results in deregulation of recombination-based activities at telomeres. Thus ALT+ cells show elevated T-SCE (telomere sister-chromatid exchange), misprocessing of t-loops that cap chromosomes and recombination-based processes between telomeres or between telomeres and ECTRs (extrachromosomal telomeric repeats). Some or all of these processes underlie the chaotic telomere length maintenance that allows cells in ALT+ tumours unlimited replicative capacity. ALT activation is also associated with destabilization of a minisatellite, MS32. The connection between the minisatellite instability and the deregulation of recombination-based activity at telomeres is not understood, but analysis of the minisatellite can be used as a marker for ALT. It is known that telomere length maintenance in ALT+ cells is dependent on the MRN [MRE11 (meiotic recombination 11)-Rad50-NBS1 (Nijmegen breakage syndrome 1)] complex, but knowledge of the role of other genes, including the Werner's (WRN) and Bloom's (BLM) syndrome DNA helicase genes, is still limited.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442255     DOI: 10.1042/BST0370589

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  9 in total

1.  TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression.

Authors:  Kyle Lafferty-Whyte; Alan Bilsland; Stacey F Hoare; Sharon Burns; Nadia Zaffaroni; Claire J Cairney; William Nicol Keith
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Hyper telomere recombination accelerates replicative senescence and may promote premature aging.

Authors:  R Tanner Hagelstrom; Krastan B Blagoev; Laura J Niedernhofer; Edwin H Goodwin; Susan M Bailey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

Review 3.  Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability.

Authors:  Venkateswarlu Popuri; Takashi Tadokoro; Deborah L Croteau; Vilhelm A Bohr
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-04-29       Impact factor: 8.250

4.  Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study.

Authors:  Andrew J Pellatt; Roger K Wolff; Abbie Lundgreen; Richard Cawthon; Martha L Slattery
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

5.  Recombination can either help maintain very short telomeres or generate longer telomeres in yeast cells with weak telomerase activity.

Authors:  Evelina Basenko; Zeki Topcu; Michael J McEachern
Journal:  Eukaryot Cell       Date:  2011-06-10

Review 6.  Telomerase deficiency and cancer susceptibility syndromes.

Authors:  Rosario Perona; Rosario Machado-Pinilla; Cristina Manguan; Jaime Carrillo
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

7.  Telomerase-independent paths to immortality in predictable cancer subtypes.

Authors:  Stephen T Durant
Journal:  J Cancer       Date:  2012-01-31       Impact factor: 4.207

8.  The roles of WRN and BLM RecQ helicases in the Alternative Lengthening of Telomeres.

Authors:  Aaron Mendez-Bermudez; Alberto Hidalgo-Bravo; Victoria E Cotton; Athanasia Gravani; Jennie N Jeyapalan; Nicola J Royle
Journal:  Nucleic Acids Res       Date:  2012-09-18       Impact factor: 16.971

Review 9.  Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.

Authors:  S L George; V Parmar; F Lorenzi; L V Marshall; Y Jamin; E Poon; P Angelini; L Chesler
Journal:  J Exp Clin Cancer Res       Date:  2020-05-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.